Pharming Group N.V.

PHARM.AS · AMS
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-€11-€12€15€22
Dep. & Amort.€16€16€13€19
Deferred Tax€0€0€0-€1
Stock-Based Comp.€11€9€6€9
Change in WC-€7-€17-€0-€5
Other Non-Cash-€10-€14-€11-€8
Operating Cash Flow-€2-€17€23€36
Investing Activities
PP&E Inv.-€1-€1-€2-€16
Net Acquisitions€0€0€7€0
Inv. Purchases-€263-€382€0-€4
Inv. Sales/Matur.€293€233€0€0
Other Inv. Act.€2€21€6-€0
Investing Cash Flow€32-€129€5-€20
Financing Activities
Debt Repay.-€34-€5-€3-€3
Stock Issued€5€0€2€5
Stock Repurch.€0€0€0€0
Dividends Paid€0€0€0€0
Other Fin. Act.-€5€4-€4-€30
Financing Cash Flow-€34-€1-€5-€27
Forex Effect-€2€2-€8€13
Net Chg. in Cash-€7-€146€15€3
Supplemental Information
Beg. Cash€62€207€192€189
End Cash€55€62€207€192
Free Cash Flow-€2-€19€21€20
Pharming Group N.V. (PHARM.AS) Financial Statements & Key Stats | AlphaPilot